All Rights Reserved. An official website of the United States government. Sign up to receive email notifications on clinical trials for individual conditions in your local area. Research advances and clinical management of bronchiectasis: Chinese 2023 American Lung Association. Medical management of bronchiectasis: more MDT would help, Respiratory follow up for Aboriginal children, Improving Aboriginal Childrens Lung Health, Bronchiectasis in the Northern Territory, Australia, Neutrophil extracellular traps bronchiectasis, Improving Aboriginal Childrens Lung Health, Brensocatib reduces exacerbations in bronchiectasis: WILLOW study, Epidemiology of bronchiectasis in the UK: Findings from the British lung foundations Respiratory health of the nation projec, Six ways that bronchiectasis treatment is at odds with guidelines. Obesity, Nutrition, and Physical Activity, Treat any underlying conditions and lung infections, Remove mucus (a slimy substance) from your lungs, An electric chest clapper, known as a mechanical percussor, An inflatable therapy vest that uses high-frequency air waves to force mucus toward your upper airways so you can cough it up, A small handheld device that you breathe out through, which causes vibrations that dislodge the mucus, A mask that creates vibrations to help break loose mucus from your airway walls. In 2021, a series of significant research progress have been made in bronchiectasis, focusing on the mechanism, diagnosis, clinical phenotypes, treatment, comorbidities, etc. Tiotropium treatment for bronchiectasis: a randomised, placebo Scenario: Infective exacerbation: Covers the management of an infective exacerbation of bronchiectasis. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. The European Respiratory Society guidelines for the management of adult bronchiectasis describe the appropriate investigation and treatment strategies determined by a systematic review of the literature. We do not capture any email address. A Spanish study showed that the mean annual costs per patient were EUR 2993, EUR 4732 and EUR 9999 for mild, moderate and severe bronchiectasis, respectively [17]. Bronchiectasis is a long-term condition with symptoms that need to be managed over many years. Bronchiectasis Toolbox. A Respiratory Syncytial Virus (RSV) vaccine clinical trial for older adults. The document summarised the epidemiology, pathogenesis, etiology, clinical diagnosis, treatment strategies and patient education of bronchiectasis in China according to a systematic review of the . Surgery may be recommended in extreme situations where the bronchiectasis is isolated to a section of lung or there is excessive bleeding.